Mesothelioma web sites continue to pick  up the pace of and quality of information disseminated regarding asbestos related diseases. A new example arises from the Surviving Mesothelioma site publishing this August 29, 2015 post about an August 24, 2015 medical article. The abstract is as follows:

The aim of our study was

After various delays, the new, more detailed ICD-10 coding takes effect in October. The ICD-10 coding is more detailed than is current coding in terms of identifying cancers by type, subtype and location. New knowledge inevitably will follow from better data. This page provides examples of the new oncology coding in general.

Here are examples

Genetics and epigenetic issues continue to knock open doors in toxic tort litigation. An example? A recent federal MDL ruling rejected defense Daubert motions seeking to strike expert opinions that were based on the concept of a cancer arising less than 1 year. How could that happen? Think epigenetic actions that “turn on” a cell

Some say that change is the predominant theme in asbestos litigation. For 2014, some of the change arrives in the form of at least five mesothelioma cases where the presence or absence of a germline  BAP1 mutation is becoming an issue. As it happens, the five cases are scattered around the country: California (3), Missouri,

Some see lung cancer claiming as associated only with the Napoli Bern law firm. But that’s not correct.  More and more, members of the Motley Rice firm (and some other firms) are talking about and taking action regarding lung cancer claims, both in and out of  asbestos litigation. Consider, for example, that the Motley Rice

The role of smoking in cancers is an increasingly litigated issue for cancers that are not lung cancer. For example, a current trial in a Takeda- Actos bladder cancer case is reported by LAW360 to include a defense expert assigning causation to “tobacco abuse,” diabetes and excess weight. According to the article:

“Mark Schoenberg, a